250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study / O'Connor, P; Filippi, M; Arnason, B; Comi, G; Cook, S; Goodin, D; Hartung, Hp; Jeffery, D; Kappos, L; Boateng, F; Filippov, V; Groth, M; Knappertz, V; Kraus, C; Sandbrink, R; Pohl, C; Bogumil, T; Amato, Mp. - In: LANCET NEUROLOGY. - ISSN 1474-4422. - STAMPA. - 8:(2009), pp. 889-897.

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.

AMATO, MARIA PIA
2009

Abstract

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
2009
8
889
897
O'Connor, P; Filippi, M; Arnason, B; Comi, G; Cook, S; Goodin, D; Hartung, Hp; Jeffery, D; Kappos, L; Boateng, F; Filippov, V; Groth, M; Knappertz, V; Kraus, C; Sandbrink, R; Pohl, C; Bogumil, T; Amato, Mp
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/398258
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 352
  • ???jsp.display-item.citation.isi??? ND
social impact